| Health / Medical Topics |
GDC-0449
A drug used to treat advanced basal cell carcinoma that has spread to other parts of the body or has come back after surgery. It is also used in patients who cannot be treated with surgery or radiation therapy. It is also being studied in the treatment of other types of cancer. GDC-0449 blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of Hedgehog signaling pathway antagonist. Also called Erivedge and vismodegib. (NCI Dictionary)
YOU MAY ALSO LIKE
GD3 Binding Interaction involves non-covalent attachment of a molecule through intermolecular physical forces of attraction to a cell surface liposaccharide disialoganglioside,…
A cancer vaccine containing an epitope of glycosphingolipid GD2 conjugated with the immunostimulant keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. …
A cancer vaccine, containing epitopes of the gangliosides GD2 and GD3 conjugated with the immunostimulant keyhole limpet hemocyanin (KLH), with potential antineoplastic…
GD2 Binding Interaction involves non-covalent attachment of a molecule through intermolecular physical forces of attraction to a widely expressed cell surface ganglioside…
A substance used in magnetic resonance imaging (MRI) to help make clear pictures of the brain, spine, heart, soft tissue of joints,…
A rare tumor that usually forms in bone, but may also form in cartilage, muscle, fat, blood vessels, or other supportive tissue…
